Sign in to add mentor
Joëlle Roche grad student 2007 Université de Poitiers. UFR des sciences fondamentales et appliquées
 (Etude des mécanismes moléculaires responsables de la fonction anti-tumorale de la semaphorine SEMA3F dans le cancer broncho-pulmonaire)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Nasarre P, Gemmill RM, Potiron VA, et al. (2013) Neuropilin-2 Is upregulated in lung cancer cells during TGF-β1-induced epithelial-mesenchymal transition. Cancer Research. 73: 7111-21
Gemmill RM, Roche J, Potiron VA, et al. (2011) ZEB1-responsive genes in non-small cell lung cancer. Cancer Letters. 300: 66-78
Nasarre P, Potiron V, Drabkin H, et al. (2010) Guidance molecules in lung cancer. Cell Adhesion & Migration. 4: 130-45
Clarhaut J, Gemmill RM, Potiron VA, et al. (2009) ZEB-1, a repressor of the semaphorin 3F tumor suppressor gene in lung cancer cells. Neoplasia (New York, N.Y.). 11: 157-66
Potiron VA, Roche J, Drabkin HA. (2009) Semaphorins and their receptors in lung cancer. Cancer Letters. 273: 1-14
Potiron VA, Sharma G, Nasarre P, et al. (2007) Semaphorin SEMA3F affects multiple signaling pathways in lung cancer cells. Cancer Research. 67: 8708-15
Loudni L, Roche J, Potiron V, et al. (2007) Design, synthesis and biological evaluation of 1,4-benzodiazepine-2,5-dione-based HDAC inhibitors. Bioorganic & Medicinal Chemistry Letters. 17: 4819-23
Potiron V, Nasarre P, Roche J, et al. (2007) Semaphorin signaling in the immune system. Advances in Experimental Medicine and Biology. 600: 132-44
Kusy S, Potiron V, Zeng C, et al. (2005) Promoter characterization of Semaphorin SEMA3F, a tumor suppressor gene. Biochimica Et Biophysica Acta. 1730: 66-76
Kusy S, Nasarre P, Chan D, et al. (2005) Selective suppression of in vivo tumorigenicity by semaphorin SEMA3F in lung cancer cells. Neoplasia (New York, N.Y.). 7: 457-65
See more...